The effect of the neutral endopeptidase inhibitor drug, candoxatril, on circulating levels of two of the most potent vasoactive peptides - Concepedia

Concepedia

Publication | Open Access

The effect of the neutral endopeptidase inhibitor drug, candoxatril, on circulating levels of two of the most potent vasoactive peptides

DOI Full Paper Access

89

Citations

0

References

1997

Year

Garry McDowell, Wendy J. Coutie, C M Shaw, K.D. Buchanan, Allan D. Struthers, DP Nicholls

British Journal of Clinical Pharmacology

Abstract

We conclude that neutral endopeptidase inhibition increases circulating plasma levels of ET and CGRP in addition to the natriuretic peptides.